معرفی
Diana S-L. Chow is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy. She also holds the Paula & John J. Lovoi Sr. Endowed Professor in Drug Discovery and Development and serves as Director of the Institute of Drug Education and Research.
- B.S. in Pharmacy, National Taiwan University, School of Pharmacy
- M.S. in Natural Product Chemistry, Ohio State University
- Ph.D. in Pharmaceutics, University of British Columbia
Dr. Chow's research spans 40 years of translational drug development with a focus on anti-cancer therapies. She has pioneered formulations resulting in FDA-approved products like Busulfex®, with ongoing work on lung, pancreatic, and prostate cancer treatments. Her recent studies expand to underrepresented minority (URM) populations, pediatrics, and neurologically injured patients, emphasizing pharmacokinetics/pharmacodynamics (PK/PD) optimization.
Her publications highlight expertise in analytical method development (e.g., LC-MS/MS assays), nanoparticle-based drug delivery, and neuroprotective agents. Key themes include preclinical-to-clinical translation, metabolite quantification, and bioavailability enhancement.
- 2023 Meritorious Achievement Award, UH College of Pharmacy
- 2023 Pharmaceutical Sciences Alumni Agent of Change, University of British Columbia
- 2016 Fellow, National Academy of Inventors
- 2009 Inventor of the Year, HIPLA
Dr. Chow mentors extensively, with recognition as Outstanding Graduate Mentor (2022, 2021), and contributes to graduate education and research infrastructure through her directorship.
